HOMAPIN LIQUITAB owner Contact Information online
from Mission Pharmacal Company
HOMAPIN LIQUITAB
US serial number:85096658
Application filling date:Jul. 30, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Oct. 03, 2011
Publication date:Jan. 04, 2011
Abandoned date:Oct. 03, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical tablets for antispasmodic treatment, for anti-secretory treatment, for anti-chlorinergic treatment, for gastroenteritis treatment, for treatment of peptic ulcers, for treatment of the prostate gland, for treatment of the eye, and for u
Current owner owner name:Mission Pharmacal Company
Current owner owner address:10999 IH 10 West, Suite 1000
San Antonio,
TEXAS
UNITED STATES
78230
Current owner legal entity type:CORPORATION
Current owner state or country:TEXAS
Attorney name:Pamela B. Huff
Attorney email:ipdocket@coxsmith.com
Attorney docket number:21262.169(B)
Attorney email authorized:Yes
Correspondent name address:PAMELA B. HUFF
COX SMITH MATTHEWS INCORPORATED
112 E PECAN ST STE 1800
SAN ANTONIO,
TEXAS
UNITED STATES
78205-1521
Correspondent phone:210-554-5450
Correspondent email:ipdocket@coxsmith.com
Correspondent fax:210-226-8395
Correspondent email authorized:Yes
Trademark staff tm attorney:SHARMA, NAPOLEON K
Trademark staff law office assigned HOMAPIN LIQUITAB:LAW OFFICE 107
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Syngenta Participations AG (18) Scott Riddell (17)Popular publication dates
Jan. 04, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
